Sclerotherapy in the management of postoperative lymphocele.

Purpose: To describe a single-center experience with sclerotherapy of postoperative lymphocele and to determine the risk factors for failure of treatment.

Materials And Methods: From 1999 to 2007, 43 patients with postsurgical lymphocele were treated with sclerotherapy with a combination of povidone iodine, alcohol, and doxycycline. The treatments were repeated at weekly intervals.

Retrievable vena cava filters in major trauma patients: prevalence of thrombus within the filter.

The purpose of this study was to report the prevalence of thrombus within a retrievable vena cava filter inserted prophylactically in major trauma patients referred for filter extraction. Between November 2002 and August 2005, 80 retrievable inferior vena cava filters (68 Optease and 12 Gunther-Tulip) were inserted into critically injured trauma patients (mean injury severity score 33.5).

How to do a session of experiential psychotherapy.

Each experiential session is to achieve two goals. One is to enable the person to undergo a qualitative shift into being the transformed new person that the person can become. A second goal is for the qualitatively new person to be essentially free of the painful feeling and scene that were front and center for the person in the session.

Introduction to a mythical family: how to do experiential psychotherapy.

Experiential psychotherapy is generally accepted as one of the major families of psychotherapy. One of the main purposes of this introduction to the theme issue is to invite leading proponents and exponents to provide their own answers to the question of how to do experiential psychotherapy, with the emphasis on what would be helpful to students, trainees, and practitioners somewhat familiar with the approach. A second main purpose is to make a case that the very idea of an "experiential family" is a myth.

Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanoma.

We have previously reported studies performed both in vitro and in laboratory animals, as well as a case study in humans, suggesting that intravenous immunoglobulin (IVIG) may be beneficial in the treatment of malignancies, including metastatic melanoma. As part of a phase II open label trial, we have administered IVIG to nine patients with metastatic melanoma who had been heavily treated. In two of nine (22%) patients treated every 3 weeks with IVIG (1 g/kg body weight), the disease stabilized.